Blue Capital Inc’s Colgate-Palmolive CL Stock Holding History

Blue Capital Inc’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,660	Closed	-$452K	–	89
2025 Q3	$452K	Buy	+5,660	New	+$483K	0.34%	64

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Blue Capital Inc's CL Position: Q4 2025 in Review

Blue Capital Inc sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 5,660 shares — an estimated $452K sold.

Blue Capital Inc first reported a position in CL in Q3 2025 and held it in 1 quarter. The position peaked at $452K in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

Blue Capital Inc reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
Blue Capital Inc sold 5,660 Colgate-Palmolive shares in Q4 2025, an estimated $452K.
Blue Capital Inc first reported a position in Colgate-Palmolive in Q3 2025 and held it in 1 quarter.
Blue Capital Inc's Colgate-Palmolive position peaked at $452K in Q3 2025.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Blue Capital Inc's 13F filing for Q4 2025, filed 23 Feb 2026.